SRI Surgical Express Inc Merger Litigation (Nasdaq: STRC)
Law Office of Brodsky & Smith, LLC Announces Investigation of SRI Surgical Express, Inc.
BALA CYNWYD, June 10, 2012/PR Newswire/ –Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of SRI Surgical Express, Inc (“SRI” or the “Company”) (Nasdaq- STRC-News) relating to the proposed acquisition by Synergy Health plc. (“Synergy”).
Under the terms of the transaction, SRI shareholders will receive only $3.70 in cash for each share of SRI stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of SRI for not acting in the Company’s shareholders' best interests in connection with the sale process to Synergy. The transaction will result in a substantial loss to long term SRI shareholders as SRI stock traded at $6.36 on February 3, 2011 and traded at $4.00 a share as recently as March 17, 2012. In addition, an analyst has set a $5.35 price target on SRI stock.
If you own shares of SRI stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com or by calling toll free 877-LEGAL-90.
To Join the SRI Surgical Express Inc Litigation
Fill out this form
The complaint is unavailable at this time